Affymetrix, Abbott sign licensing deal

By Elaine Rigoli

Tampa, Fla., April 5 - Affymetrix, Inc. said Abbott Molecular, a division of Abbott, has obtained a non-exclusive worldwide license to a number of Affymetrix patents that will allow it to manufacture and sell comparative genomic hybridization microarrays, related readers and software in the research and diagnostics field.

The companies did not disclose further details of the license.

Abbott Molecular develops information-based products for the early detection of pathogens and has headquarters in Abbott Park, Ill.

Affymetrix develops microarray technology and has headquarters in Santa Clara, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.